A novel screening system for claudin binder using baculoviral display

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Kakutani, Hideki ^a   Takahashi, Azusa ^a   Kondoh, Masuo ^a   Saito, Yumiko ^a   Yamaura, Toshiaki ^a   Sakihama, Toshiko ^b   Hamakubo, Takao ^b   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 4; CLOSTRIDIUM TOXIN; ENTEROTOXIN; ENTEROTOXIN, CLOSTRIDIUM; LIGAND; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PEPTIDE LIBRARY;

ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; MOLECULAR LIBRARY; NONHUMAN; PHAGE DISPLAY; PROTEIN BINDING; PROTEIN FUNCTION; TIGHT JUNCTION; AMINO ACID SEQUENCE; ANIMAL; ARMYWORM; CELL CULTURE; CELL STRAIN CACO 2; CHEMISTRY; EVALUATION; GENETICS; HIGH THROUGHPUT SCREENING; HUMAN; METABOLISM; METHODOLOGY; OSMOLARITY; PHYSIOLOGY; PROTEIN ANALYSIS;

CLOSTRIDIUM PERFRINGENS;

AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; CACO-2 CELLS; CELLS, CULTURED; ENTEROTOXINS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIGANDS; MEMBRANE PROTEINS; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SPODOPTERA;

EID: 79951885586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016611     Document Type: Article

References (36)

1. Farquhar MG, Palade GE, (1963) Junctional complexes in various epithelia. J Cell Biol 17: 375-412.
2. Anderson JM, Van Itallie CM, Fanning AS, (2004) Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 16: 140-145.
3. Balda MS, Matter K, (1998) Tight junctions. J Cell Sci 111 (Pt 5): 541-547.
4. Tsukita S, Furuse M, Itoh M, (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293.
5. Mitic LL, Anderson JM, (1998) Molecular architecture of tight junctions. Annu Rev Physiol 60: 121-142.
6. Wodarz A, Nathke I, (2007) Cell polarity in development and cancer. Nat Cell Biol 9: 1016-1024.
7. Schneeberger EE, Lynch RD, (2004) The tight junction: a multifunctional complex. Am J Physiol 286: C1213-C1228.
8. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, et al. (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156: 1099-1111.
9. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, et al. (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161: 653-660.
10. McClane BA, (1994) Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes. Toxicology 87: 43-67.
11. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N, (1997) Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 136: 1239-1247.
12. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, et al. (1999) Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 147: 195-204.
13. Kondoh M, Masuyama A, Takahashi A, Asano N, Mizuguchi H, et al. (2005) A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol 67: 749-756.
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
15. Kominsky SL, (2006) Claudins: emerging targets for cancer therapy. Expert Rev Mol Med 8: 1-11.
16. Morin PJ, (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606.
17. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, et al. (2001) Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121: 678-684.
18. Santin AD, Cane S, Bellone S, Palmieri M, Siegel ER, et al. (2005) Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer Res 65: 4334-4342.
19. Loisel TP, Ansanay H, St-Onge S, Gay B, Boulanger P, et al. (1997) Recovery of homogeneous and functional beta 2-adrenergic receptors from extracellular baculovirus particles. Nat Biotechnol 15: 1300-1304.
20. Sakihama T, Masuda K, Sato T, Doi T, Kodama T, et al. (2008) Functional reconstitution of G-protein-coupled receptor-mediated adenylyl cyclase activation by a baculoviral co-display system. J Biotechnol 135: 28-33.
21. Sakihama T, Sato T, Iwanari H, Kitamura T, Sakaguchi S, et al. (2008) A simple detection method for low-affinity membrane protein interactions by baculoviral display. PLoS ONE 3: e4024.
22. Ebihara C, Kondoh M, Hasuike N, Harada M, Mizuguchi H, et al. (2006) Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin. J Pharmacol Exp Ther 316: 255-260.
23. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, et al. (2000) Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 476: 258-261.
24. Takahashi A, Komiya E, Kakutani H, Yoshida T, Fujii M, et al. (2008) Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem Pharmacol 75: 1639-1648.
25. Meunier V, Bourrie M, Berger Y, Fabre G, (1995) The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 11: 187-194.
26. Hanna PC, Mietzner TA, Schoolnik GK, McClane BA, (1991) Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. J Biol Chem 266: 11037-11043.
27. Offner S, Hekele A, Teichmann U, Weinberger S, Gross S, et al. (2005) Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunol Immunother 54: 431-445.
28. Ling J, Liao H, Clark R, Wong MS, Lo DD, (2008) Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J Biol Chem 283: 30585-30595.
29. Suzuki M, Kato-Nakano M, Kawamoto S, Furuya A, Abe Y, et al. (2009) Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 100: 1623-1630.
30. Romani C, Comper F, Bandiera E, Ravaggi A, Bignotti E, et al. (2009) Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. Am J Obstet Gynecol 201: 70 e71-79.
31. Furuse M, Furuse K, Sasaki H, Tsukita S, (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153: 263-272.
32. Furuse M, Sasaki H, Tsukita S, (1999) Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147: 891-903.
33. Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, et al. (2006) ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 126: 741-754.
34. Masuda K, Itoh H, Sakihama T, Akiyama C, Takahashi K, et al. (2003) A combinatorial G protein-coupled receptor reconstitution system on budded baculovirus. J Biol Chem 278: 24552-24562.
35. Hayashi I, Urano Y, Fukuda R, Isoo N, Kodama T, et al. (2004) Selective reconstitution and recovery of functional gamma-secretase complex on budded baculovirus particles. J Biol Chem 279: 38040-38046.
36. Saeki R, Kondoh M, Kakutani H, Tsunoda S, Mochizuki Y, et al. (2009) A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol Pharmacol 76: 918-926.